A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer

被引：0
|
作者：
Lin, Y. [1 ]
Qin, S. [2 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China
[2] Peoples Liberat Army Canc Ctr, Nanjing, Jiangsu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer
    Lin, Y.
    Qin, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
    Brose, Marcia S.
    Nutting, Christopher M.
    Jarzab, Barbara
    Elisei, Rossella
    Siena, Salvatore
    Bastholt, Lars
    de la Fouchardiere, Christelle
    Pacini, Furio
    Paschke, Ralf
    Shong, Young Kee
    Sherman, Steven I.
    Smit, Johannes W. A.
    Chung, John
    Kappeler, Christian
    Pena, Carol
    Molnar, Istvan
    Schlumberger, Martin J.
    LANCET, 2014, 384 (9940): : 319 - 328
  • [3] Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
    Lin, Yansong
    Qin, Shukui
    Yang, Hui
    Shi, Feng
    Yang, Aimin
    Han, Xingmin
    Liu, Bin
    Li, Zhiyong
    Ji, Qinghai
    Tang, Lijun
    Deng, Zhiyong
    Ding, Yong
    Fu, Wei
    Xie, Xianhe
    Li, Linfa
    He, Xiaohui
    Lv, Zhongwei
    Ma, Qingjie
    Shen, Zan
    Guo, Zhuming
    Chen, Zhendong
    Cui, Yali
    Tan, Jian
    Gao, Zairong
    Jing, Shanghua
    Lu, Keyi
    Luo, Xianyang
    Zhang, Yuan
    Fang, Yong
    Li, Zhendong
    Cheng, Yizhuang
    Lei, Shangtong
    Luan, Sha
    Chen, Guang
    Wang, Guihua
    Wu, Liqing
    Liu, Lingling
    CLINICAL CANCER RESEARCH, 2023, 29 (15) : 2791 - 2799
  • [4] Donafenib in locally advanced/metastatic, radioactive iodine-refractory, differentiated thyroid cancer: A randomized, double-blind, placebo-controlled, multi-center phase III clinical trial (DIRECTION)
    Lin, Y.
    Yang, H.
    Shi, F.
    Yang, A.
    Han, X.
    Liu, B.
    Li, Z.
    Ji, Q.
    Tang, L.
    Deng, Z.
    Ding, Y.
    Fu, W.
    Xie, X.
    Li, L.
    He, X.
    Lv, Z.
    Wu, L.
    Liu, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1294 - S1294
  • [5] Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
    Kapoor, Raju
    Furby, Julian
    Hayton, Thomas
    Smith, Kenneth J.
    Altmann, Daniel R.
    Brenner, Robert
    Chataway, Jeremy
    Hughes, Richard A. C.
    Miller, David H.
    LANCET NEUROLOGY, 2010, 9 (07): : 681 - 688
  • [6] Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial
    Lin, Yansong
    Qin, Shukui
    Li, Zhiyong
    Yang, Hui
    Fu, Wei
    Li, Shaohua
    Chen, Wenxin
    Gao, Zairong
    Miao, Weibing
    Xu, Huiqin
    Zhang, Qing
    Zhao, Xinming
    Bao, Jiandong
    Li, Linfa
    Ren, Yuan
    Lin, Chenghe
    Jing, Shanghua
    Ma, Qingjie
    Liang, Jun
    Chen, Guang
    Zhang, Hong
    Zhang, Yifan
    Zhou, Xianfeng
    Sang, Yaxiong
    Hou, Zhiguo
    JAMA ONCOLOGY, 2022, 8 (02) : 242 - 250
  • [7] Effectiveness of quinine in treating muscle cramps: A double-blind, placebo-controlled, parallel-group, multicentre trial
    Diener, HC
    Dethlefsen, U
    Dethlefsen-Gruber, S
    Verbeek, P
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (04) : 243 - 246
  • [8] SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL
    Venhoff, N.
    Schmidt, W. A.
    Bergner, R.
    Rech, J.
    Unger, L.
    Tony, H. P.
    Mendelson, M.
    Sieder, C.
    Maricos, M.
    Thiel, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 121 - 122
  • [9] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhardsen, Gerhard
    Hansen, Anne V.
    Killi, Marianne
    Fornitz, Gitte Gleerup
    Pedersen, Frank
    Roos, Signe Barfod
    ADVANCES IN THERAPY, 2008, 25 (06) : 595 - 607
  • [10] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhard Gerhardsen
    Anne V. Hansen
    Marianne Killi
    Gitte Gleerup Fornitz
    Frank Pedersen
    Signe Barfod Roos
    Advances in Therapy, 2008, 25
12345